Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel.
about
CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies.Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel.Cytokine release syndrome: grading, modeling, and new therapy
P2860
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Grading of cytokine release sy ...... cell therapy tisagenlecleucel.
@en
Grading of cytokine release sy ...... cell therapy tisagenlecleucel.
@nl
type
label
Grading of cytokine release sy ...... cell therapy tisagenlecleucel.
@en
Grading of cytokine release sy ...... cell therapy tisagenlecleucel.
@nl
prefLabel
Grading of cytokine release sy ...... cell therapy tisagenlecleucel.
@en
Grading of cytokine release sy ...... cell therapy tisagenlecleucel.
@nl
P2093
P2860
P921
P1476
Grading of cytokine release sy ...... cell therapy tisagenlecleucel.
@en
P2093
David Porter
Noelle Frey
Patricia A Wood
Stephan A Grupp
Yanqiu Weng
P2860
P2888
P356
10.1186/S13045-018-0571-Y
P577
2018-03-02T00:00:00Z
P6179
1101304993